Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening
Status unconfirmed · Not applicable · Has a placebo group
Conditions studied: Proximal Muscle Strength, Proximal Muscle Lengthening
In brief
The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein.
Key facts
- Study ID
- NCT05710757
- Run by
- University of Tennessee
- People needed
- 60
- Starts
- 2023-10-16
- Expected to finish
- 2024-09-01
- Last updated by the study team
- 2024-03-20
Who can join
Age: 18 and older, up to 30. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy individuals between the age of 18 and 30
You may not qualify if…
- Individuals with uncontrolled high blood pressure
- Individuals with sickle cell anemia, current pregnancy
- Individuals with a history of deep vein thrombosis
- Individuals with diabetes
- Individuals with active infection
- Individuals with less than normal range of motion or muscle strength
- Individuals with moderate to severe upper extremity injury in the past 12 months
- Individuals with a current diagnosis of cancer.
Where it is running
- University of Tennessee Health Science Center — Memphis, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.